Home
Off-the-shelf
Humanized mice (target-specific)
genO‑hIgE/hFcεR1
Humanized mice (target-specific)

Humanized genO‑hIgE/hFcεR1 mouse model

Use the genO‑hIgE/hFcεR1 mouse model to successfully screen for innovative therapeutics for allergy, asthma and other IgE-mediated diseases.

Contact Us

Applications of the genO‑hIgE/hFcεR1 mouse model

Useful applications for researchers working in immuno-inflammation and allergic diseases: 

  • Assess the efficacy of IgE-targeting therapeutics
    • Test therapeutics that block anaphylaxis (passive or active) and help controling asthma
  • Develop models of Passive Cutaneous Anaphylaxis (PCA), OVA hypersensitivity and Passive systemic anaphylaxis (PSA)
  • Investigate the mode of action (MoA) of various compounds and understand their therapeutic potential

 

 Features

  • Human-like cellular distribution (i.e., mast cells, basophils, monocytes/DCs, Langerhans cells, and eosinophils) of the FcεR1 receptor
  • Physiological regulation and expression of the chimeric IgE/FcεR1 complex
  • Preservation of ligand-receptor interaction
  • Preservation of the Ig class switching mechanism
  • Human IgE is present, but at low levels
  • Fully functional mouse immune system
  • Lack of expression of the murine target genes

Clients

Carterra

Scientific articleScientific articlePosterPoster

IgGenix

Scientific articleScientific articlePosterPoster

Ambiotis

Scientific articleScientific articlePosterPoster

Seismic Therapeutic

Scientific articleScientific articlePosterPoster

Model Delivery & Logistics

  • Breeding facilities in the US and Europe through our trusted partners:
  • Quick, compliant, and reliable door-to-door delivery worldwide
  • Models with certified SOPF health status from AAALAC-accredited and PHS-assured professional breeders in the US and Europe

Validation data

Discover related products to

genO‑hIgE/hFcεR1

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
HSA
PK/PD
Fc receptor
KO-Rep-Mix

genO‑HSA/hFcRn-RAG1KO

This upgraded, immunocompromised RAG1-/- version of our genO-HSA/hFcRn mouse model allows the assessment of compounds' half-life and anti-tumor efficacy in a human tumor model.

CD4
Inflammation
T-cell receptor

genO‑hCD4

The humanized genO‑hCD4 mouse model allows in vivo efficacy and safety assessment of anti-human CD4 compounds.

‍

FcgR
Fc receptor

genO‑hFcγR

Preclinical humanized Fc-gamma receptor (genO‑hFcγR) model enabling the assessment of Fc receptor pathways targeted therapies.

‍

HSA
PK/PD
Fc receptor

genO‑hSA/hFcRn

Double humanized genO‑hSA/hFcRn mouse model as a cutting-edge platform for preclinical development of hSA and FcRn-oriented therapeutics.

FcgR
Fc receptor
TFRC
Drug shuttling

genO‑hTFRC/hFcγR

Double-humanized genO-hTFRC/hFcγR mouse model to improve biodistribution and enable drug shuttling through the blood-brain barrier (BBB).

‍

Inflammation
TNF
Cytokine

genO‑hTNF-α

The genO‑hTNF-α model provides new opportunities for assessment of anti-TNF therapies.

Humanized genO‑hIgE/hFcεR1 mouse model

Get in touch about

Let us know how we can help

Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe